ANTIBODY FORMULATION

The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent. La présente invention concerne des for...

Full description

Saved in:
Bibliographic Details
Main Authors PURI, MANASI, DUNLEAVY, DONNA M, BLAKE-HASKINS, ANGELA, PERKINS, MELISSA D, CROTTS, GEORGE H, MARSHALL, TRISTAN, O'BERRY, KRISTEN
Format Patent
LanguageEnglish
French
Published 19.12.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent. La présente invention concerne des formulations pharmaceutiques à base d'une protéine de liaison à un antigène pharmaceutiquement active, par exemple de type anticorps monoclonal. Ces formulations comprennent, en plus de la protéine de liaison à un antigène, un agent tampon et un agent de tonicité.
Bibliography:Application Number: CA20152949212